{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:22:21Z","timestamp":1794385341208,"version":"4.9.0"},"reference-count":72,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2019,5,29]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Glycyrrhizic acid (GA), a triterpene isolated from the roots and rhizomes of licorice, named\nGlycyrrhiza glabra, is the principal bioactive ingredient of anti-viral, anti-inflammatory and hepatoprotective\neffects. GA has been used in the clinical treatment of hepatitis, bronchitis, gastric ulcer, AIDS\n(acquired immunodeficiency syndrome), certain cancers and skin diseases. It has a direct effect on\nanti-HBV (hepatitis B virus) via affecting the HBsAg (hepatitis B surface antigen) to extracellular secretion,\nimproving liver dysfunction in patients with chronic hepatitis B, and ultimately improving the\nimmune status of HBV. GA can significantly inhibit the proliferation of HIV, showing an immune activation.\nThe clinical application of GA on the prevention and treatments of various diseases may derive\nfrom its numerous pharmacological properties. This review provides the summary of the antiviral\neffects of GA on research progress and mechanism in recent years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389557519666190119111125","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T14:34:43Z","timestamp":1547908483000},"page":"826-832","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["Research Progress of Glycyrrhizic Acid on Antiviral Activity"],"prefix":"10.2174","volume":"19","author":[{"given":"Zhi-Gang","family":"Sun","sequence":"first","affiliation":[{"name":"State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, No. 163 Xianlin Road, Nanjing 210023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, No. 163 Xianlin Road, Nanjing 210023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lu","sequence":"additional","affiliation":[{"name":"Linyi Food and Drug Inspection and Testing Center, No. 309 Yizhou Road, Linyi 276000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-An","family":"Yang","sequence":"additional","affiliation":[{"name":"Elion Nature Bio Tech Co. Ltd. Nanjing 210038, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Liang","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, No. 163 Xianlin Road, Nanjing 210023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ptr.2295","volume":"22","author":"Fiore C.","year":"2008","unstructured":"Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, Bielenberg J.  Antiviral effects of Glycyrrhiza species.","journal-title":"Phytother Res"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/01616412.2017.1316903","volume":"39","author":"Li Y.","year":"2017","unstructured":"Li Y, Sun F, Jing Z, Wang X, Hua X, Wan L.  Glycyrrhizic acid exerts anti-inflammatory effect to improve cerebral vasospasm secondary to subarachnoid hemorrhage in a rat model.","journal-title":"Neurol Res"},{"key":"ref=3","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4569521","volume":"2016","author":"Pang H.","year":"2016","unstructured":"Pang H, Huang T, Song J, Li D, Zhao Y, Ma X.  Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI  its anti-inflammatory effect.","journal-title":"Mediators Inflamm"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-015-0133-1","volume":"38","author":"Akman T.","year":"2015","unstructured":"Akman T, Guven M, Aras AB, Ozkan A, Sen HM, Okuyucu A, Kalkan Y, Sehitoglu I, Silan C, Cosar M.  The neuroprotective effect of glycyrrhizic acid on an experimental model of focal cerebral ischemia in rats.","journal-title":"Inflammation"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cbi.2014.07.001","volume":"220","author":"Orazizadeh M.","year":"2014","unstructured":"Orazizadeh M, Fakhredini F, Mansouri E, Khorsandi L.  Effect of glycyrrhizic acid on titanium dioxide nanoparticles-induced hepatotoxicity in rats.","journal-title":"Chem Biol Interact"},{"key":"ref=6","first-page":"1","volume":"29","author":"Ojha S.","year":"2015","unstructured":"Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME.  Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of parkinson\u2019s disease.","journal-title":"Neurotox Res"},{"key":"ref=7","first-page":"415","volume":"8","author":"Ming L.J.","year":"2013","unstructured":"Ming LJ, Yin AC.  Therapeutic effects of glycyrrhizic acid.","journal-title":"Nat Prod Commun"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2017.08.123","volume":"95","author":"Su X.","year":"2017","unstructured":"Su X, Wu L, Hu M, Dong W, Xu M, Zhang P.  Glycyrrhizic acid: A promising carrier material for anticancer therapy.","journal-title":"Biomed Pharmacother"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/jm0493008","volume":"48","author":"Hoever G.","year":"2005","unstructured":"Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L.  GAT; HWD; Cinatl, J. Antiviral activity of glycyrrhizic acid derivatives against SARS\u2212coronavirus.","journal-title":"J Med Chem"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/0929867033368538","volume":"10","author":"Baltina L.A.","year":"2003","unstructured":"Baltina LA.  Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine.","journal-title":"Curr Med Chem"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.01.160","volume":"79","author":"Lin J.C.","year":"2008","unstructured":"Lin JC, Cherng JM, Hung MS, Baltina LA, Baltina L, Kondratenko R.  Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure-activity relationships.","journal-title":"Antiviral Res"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0166-3542(87)90025-8","volume":"7","author":"Baba M.","year":"1987","unstructured":"Baba M, Shigeta S.  Antiviral activity of glycyrrhizin against varicella-zoster virus","journal-title":"Antiviral Res"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0308-8146(90)90159-2","volume":"38","author":"Fenwick G.R.","year":"1990","unstructured":"Fenwick GR, Lutomski J, Nieman C.  Liquorice, Glycyrrhiza glabra L.\u2014Composition, uses and analysis.","journal-title":"Food Chem"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1248\/bpb.24.912","volume":"24","author":"Hayashi H.","year":"2001","unstructured":"Hayashi H, Huang P, Kirakosyan A, Inoue K, Hiraoka N, Ikeshiro Y, Kushiro T, Shibuya M, Ebizuka Y.  Cloning and characterization of a cDNA encoding beta-amyrin synthase involved in glycyrrhizin and soyasaponin biosyntheses in licorice.","journal-title":"Biol Pharm Bull"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1743-422X-3-68","volume":"3","author":"Shaneyfelt M.E.","year":"2006","unstructured":"Shaneyfelt ME, Burke AD, Graff JW, Jutila MA, Hardy ME.  Natural products that reduce rotavirus infectivity identified by a cell-based moderate-throughput screening assay.","journal-title":"Virol J"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.158.25","volume":"158","author":"Mori K.","year":"1989","unstructured":"Mori K, Sakai H, Suzuki S, Sugai K, Akutsu Y, Ishikawa M, Seino Y, Ishida N, Uchida T, Kariyone S.  Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV infection.","journal-title":"Tohoku J Experiment Med"},{"key":"ref=17"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20051069","volume":"392","author":"Harada S.","year":"2005","unstructured":"Harada S.  The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope.","journal-title":"Biochem J"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11172-014-0573-z","volume":"63","author":"Selyutina O.Y.","year":"2014","unstructured":"Selyutina OY, Polyakov NE, Korneev DV, Zaitsev BN.  Effect of glycyrrhizic acid on hemolysis of red blood cells and properties of cell membranes.","journal-title":"Russ Chem Bull"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s11172-015-1040-1","volume":"64","author":"Selyutina O.Y.","year":"2015","unstructured":"Selyutina OY, Apanasenko IE, Polyakov NE.  Membrane-modifying activity of glycyrrhizic acid.","journal-title":"Russ Chem Bull"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1134\/S1068162009040141","volume":"35","author":"Baltina L.A.","year":"2009","unstructured":"Baltina LA, Kondratenko RM, Baltina LA, Nzh B, Pliasunova OA.  Synthesis and biological activity of new glycyrrhizic acid conjugates with amino acids and dipeptides.","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1745-6150-1-29","volume":"1","author":"Koonin E.V.","year":"2006","unstructured":"Koonin EV, Senkevich TG, Dolja VV.  The ancient Virus World and evolution of cells.","journal-title":"Biol Direct"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.celrep.2017.03.071","volume":"19","author":"Estoppey D.","year":"2017","unstructured":"Estoppey D, Lee CM, Janoschke M, Lee BH, Wan KF, Dong H, Mathys P, Filipuzzi I, Schuhmann T, Riedl R.  The natural product cavinafungin selectively interferes with zika and dengue virus replication by inhibition of the host signal peptidase.","journal-title":"Cell Rep"},{"key":"ref=24","first-page":"199","volume":"12","author":"van Rossum T.G.","year":"1998","unstructured":"van Rossum TG, Vulto AG, de Man RA, Brouwer JT, Schalm SW.  Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment.","journal-title":"Pharmacol Ther"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/S0002-9270(01)02612-0","volume":"96","author":"van Rossum T.G.","year":"2001","unstructured":"van Rossum TG, Vulto AG, Hop WC, Schalm SW.  Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C.","journal-title":"Am J Gastroenterol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1478-3231.2007.01492.x","volume":"27","author":"Hidaka I.","year":"2007","unstructured":"Hidaka I, Hino K, Korenaga M, Gondo T, Nishina S, Ando M, Okuda M, Sakaida I.  Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.","journal-title":"Liver Int"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0168-8278(94)80108-8","volume":"21","author":"Takahara T.","year":"1994","unstructured":"Takahara T, Watanabe A, Shiraki K.  Effects of glycyrrhizin on hepatitis B surface antigen: A biochemical and morphological study.","journal-title":"J Hepatol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0166-3542(96)00942-4","volume":"30","author":"Sato H.","year":"1996","unstructured":"Sato H, Goto W, Yamamura J, Kurokawa M, Kageyama S, Takahara T, Watanabe A, Shiraki K.  Therapeutic basis of glycyrrhizin on chronic hepatitis B.","journal-title":"Antiviral Res"},{"key":"ref=29","first-page":"1437","volume":"31","author":"Tao X.","year":"2013","unstructured":"Tao X, Lou L, Xiaofei LI, Chen Y, Weiwei YE, Shuang WU.  Efficacy of glycyrrhizic acid monopotassium salt tablet in treatment of chronic hepatitis B.","journal-title":"Chin Arch Tradit Chin Med"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2007-969714","volume":"50","author":"Kiso Y.","year":"1984","unstructured":"Kiso Y, Tohkin M, Hikino H, Hattori M, Sakamoto T, Namba T.  Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation.","journal-title":"Planta Med"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1043-6618(02)00121-4","volume":"46","author":"Jeong H.G.","year":"2002","unstructured":"Jeong HG, You HJ, Park SJ, Moon AR, Chung YC, Kang SK, Chun HK.  Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression.","journal-title":"Pharmacol Res"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(00)00123-6","volume":"20","author":"Tandon A.","year":"2001","unstructured":"Tandon A, Tandon BN, Bhujwala RA.  Treatment of subacute hepatitis with Lamivudine and intravenous Glycyrrhizin: A pilot study.","journal-title":"Hepatol Res Off J Japan Soc Hepatol"},{"key":"ref=33","volume":"96","author":"Kang F.B.","year":"2017","unstructured":"Kang FB, Wang L, Sun DX.  Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy.","journal-title":"A case report Medicine"},{"key":"ref=34","first-page":"77","volume":"13","author":"Song-Qi B.U.","year":"2018","unstructured":"Song-Qi BU, Xia QQ, Zhong-Ping PU, Wards T.  Clinical therapeutic effects on chronic viral hepatitis B in the patients treated with the compound chinese herbal formula and western medicine.","journal-title":"World J Integrat Tradit West Med"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20032","volume":"39","author":"Penin F.","year":"2004","unstructured":"Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM.  Structural biology of hepatitis C virus.","journal-title":"Hepatology"},{"key":"ref=36","volume":"8","author":"Matsumoto Y.","year":"2013","unstructured":"Matsumoto Y, Matsuura T, Aoyagi H, Matsuda M, Hmwe SS, Date T, Watanabe N, Watashi K, Suzuki R, Ichinose S.  Antiviral activity of glycyrrhizin against hepatitis C virus","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1479-5876-9-112","volume":"9","author":"Ashfaq U.A.","year":"2011","unstructured":"Ashfaq UA, Masoud MS, Nawaz Z, Riazuddin S.  Glycyrrhizin as antiviral agent against Hepatitis C Virus.","journal-title":"J Transl Med"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B","volume":"79","author":"Arase Y.","year":"1997","unstructured":"Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kumada H.  The long term efficacy of glycyrrhizin in chronic hepatitis C patients.","journal-title":"Cancer"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2006.05.015","volume":"45","author":"Orlent H.","year":"2006","unstructured":"Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, Kullak-Ublick GA, Gerken G, Zeuzem S, Nevens F, Tielemans WCM.  Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trial.","journal-title":"J Hepatol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2003.11.005","volume":"62","author":"Cherng J-M.","year":"2004","unstructured":"Cherng J-M, Lin H-J, Hsu Y-H, Hung M-S, Lin J-C.  A quantitative bioassay for HIV-1 gene expression based on UV activation: effect of glycyrrhizic acid.","journal-title":"Antiviral Res"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000069334","volume":"70","author":"Sasaki H.","year":"2002","unstructured":"Sasaki H, Takei M, Kobayashi M, Pollard RB, Suzuki F.  Effect of glycyrrhizin, an active component of licorice roots, on hiv replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients.","journal-title":"Pathobiology"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0676.1998.tb00147.x","volume":"18","author":"Wang J.","year":"1998","unstructured":"Wang J, Guo J, Liu S.  Inhibitory effect of glycyrrhizin on NF-kappa B binding activity in CCl4 plus ethanol induced liver cirrhosis in rats.","journal-title":"Liver Int"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1021\/jm500763m","volume":"57","author":"Wang C.","year":"2014","unstructured":"Wang C, Lu L, Na H, Li X, Wang Q, Jiang X, Xu X, Yu F, Zhang T, Li J.  Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: A promising strategy for discovering new antiviral therapeutics.","journal-title":"J Med Chem"},{"key":"ref=44","first-page":"727","volume":"30","author":"Zheng C.G.","year":"2017","unstructured":"Zheng CG, Wu CQ, Xue MH, Ma ZH.  Clinical study of thymopentin combined with glycyrrhizin in the treatment of liver damage in patients with HIV\/AIDS.","journal-title":"Heilongjiang Med J"},{"key":"ref=45","first-page":"966","volume":"50","author":"Chen X.X.","year":"2015","unstructured":"Chen XX, Zhou HX, Qi WB, Ning ZY, Ma YJ, Li YL, Wang GC, Chen JX.  Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection .","journal-title":"Acta pharmaceutica Sinica"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/AAC.41.3.551","volume":"41","author":"Utsunomiya T.","year":"1997","unstructured":"Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F.  Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.antiviral.2009.04.012","volume":"83","author":"Wolkerstorfer A.","year":"2009","unstructured":"Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH.  Glycyrrhizin inhibits influenza A virus uptake into the cell.","journal-title":"Antiviral Res"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jep.2012.05.061","volume":"143","author":"Hsieh C.F.","year":"2012","unstructured":"Hsieh CF, Lo CW, Liu CH, Lin S, Yen HR, Lin TY, Horng JT.  Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.","journal-title":"J Ethnopharmacol"},{"key":"ref=49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019705","volume":"6","author":"Michaelis M.","year":"2011","unstructured":"Michaelis M, Geiler J, Naczk P, Sithisarn P, Leutz A, Doerr HW, Cinatl J.  Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression.","journal-title":"PLoS One"},{"key":"ref=50"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.bmcl.2015.02.074","volume":"25","author":"Baltina L.A.","year":"2015","unstructured":"Baltina LA, Zarubaev VV, Baltina LA, Orshanskaya IA, Fairushina AI, Kiselev OI, Yunusov MS.  Glycyrrhizic acid derivatives as influenza A\/H1N1 virus inhibitors.","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bmc.2017.09.038","volume":"26","author":"Tsuji M.","year":"2018","unstructured":"Tsuji M, Sriwilaijaroen N, Inoue H, Miki K, Kinoshita K, Koyama K, Furuhata K, Suzuki Y, Takahashi K.  Synthesis and anti-influenza virus evaluation of triterpene-sialic acid conjugates.","journal-title":"Bioorg Med Chem"},{"key":"ref=53","first-page":"51","volume":"45","author":"Sekizawa T.","year":"2001","unstructured":"Sekizawa T, Yanagi KY.  Glycyrrhizin increases survival of mice with herpes simplex encephalitis.","journal-title":"Acta Virol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/095632020101200206","volume":"12","author":"Lampi G.","year":"2001","unstructured":"Lampi G, Deidda D, Pinza M, Pompei R.  Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins.","journal-title":"Antivir Chem Chemother"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(03)00030-5","volume":"59","author":"Lin J.C.","year":"2003","unstructured":"Lin JC.  Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication","journal-title":"Antiviral Res"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI200523334","volume":"115","author":"Curreli F.","year":"2005","unstructured":"Curreli F, Friedman-Kien AE, Flore O.  Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.","journal-title":"J Clin Invest"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1128\/JVI.00720-11","volume":"85","author":"Kang H.","year":"2011","unstructured":"Kang H, Lieberman PM.  Mechanism of glycyrrhizic acid inhibition of kaposi\u2019s sarcoma-associated herpesvirus: Disruption of CTCF-Cohesin-Mediated RNA Polymerase II pausing and sister chromatid cohesion.","journal-title":"J Virol"},{"key":"ref=58","first-page":"2121","volume":"38","author":"Wang Y.H.","year":"2016","unstructured":"Wang YH, Lan WY, Chen T.  Antiviral effects of glycyrrhizic acid on human cytomegalovirus AD169 strain","journal-title":"Chin Tradit Pat Med"},{"key":"ref=59","first-page":"111","volume":"53","author":"Yang G.","year":"2015","unstructured":"Yang G.  Clinical effects of valaciclovir combined with compound glycyrrhizin in the treatment of herpes zoster.","journal-title":"China Modern Doctor"},{"key":"ref=60","first-page":"109","volume":"5","author":"Kai L.I.","year":"2015","unstructured":"Kai LI, Tan Y, Liu Z, Department M.  The clinical curative effect of acyclovir combined with Glycyrrhizin in treatment of herpes zoster and postherpetic neuralgia.","journal-title":"China Med Pharm"},{"key":"ref=61","first-page":"641","volume":"27","author":"Liu L.","year":"2013","unstructured":"Liu L, Zhang XB.  Therapeutic Efficacy Observation of Famciclovir Combined with Compound Glycyrrhizin for Recurrent Genital Herpes.","journal-title":"Chin J Dermatovenereol"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","volume":"361","author":"Cinatl J.","year":"2003","unstructured":"Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.","journal-title":"Lancet"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","volume":"31","author":"Chen F.","year":"2004","unstructured":"Chen F, Chan KH, Jiang Y, Kao RY, Lu HT, Fan KW, Cheng VC, Tsui WH, Hung IF, Lee TS.  \n susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.","journal-title":"J Clin Virol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2174\/092986706777584988","volume":"13","author":"Wu Y.S.","year":"2006","unstructured":"Wu YS, Lin WH, Hsu JT, Hsieh HP.  Antiviral drug discovery against SARS-CoV.","journal-title":"Curr Med Chem"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MAJ.0b013e31823e2867","volume":"344","author":"Zhang H.","year":"2012","unstructured":"Zhang H, Song Y, Zhang Z.  Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice.","journal-title":"Am J Med Sci"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jep.2013.02.017","volume":"147","author":"Wang J.","year":"2013","unstructured":"Wang J, Chen X, Wang W, Zhang Y, Yang Z, Jin Y, Ge HM, Li E, Yang G.  Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.","journal-title":"J Ethnopharmacol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0006-291X(88)80292-4","volume":"157","author":"Ohtsuki K.","year":"1988","unstructured":"Ohtsuki K, Iahida N.  Inhibitory effect of glycyrrhizin on polypeptide phosphorylation by polypeptide-dependent protein kinase (kinase P)","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=68","first-page":"91","volume":"29","author":"Badam L.","year":"1997","unstructured":"Badam L.  \n antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus.","journal-title":"J Commun Dis"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(02)00185-7","volume":"58","author":"Crance J.M.","year":"2003","unstructured":"Crance JM, Scaramozzino N, Jouan A, Garin D.  Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses.","journal-title":"Antiviral Res"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2174\/1573413711666150123230335","volume":"11","author":"Wang W.","year":"2015","unstructured":"Wang W, Zhao Y, Zhao X, Zu Y, Fu Y.  Anti-HSV-1 Activity of Glycyrrhizic Acid Nanoparticles Prepared by Supercritical Antisolvent Process.","journal-title":"Curr Nanosci"},{"key":"ref=71","first-page":"13","volume":"26","author":"Wei L.U.","year":"2014","unstructured":"Wei LU, Liu FJ, Han ZL, Hospital LP, Zibo S.  Observation of clinical curative effects of compound glycyrrhizin injection in treatment of hand-foot-mouth disease.","journal-title":"Med J Chin Peoples Health"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.antiviral.2015.06.001","volume":"120","author":"Duan E.","year":"2015","unstructured":"Duan E, Wang D, Fang L, Ma J, Luo J, Chen H, Li K, Xiao S.  Suppression of porcine reproductive and respiratory syndrome virus proliferation by glycyrrhizin.","journal-title":"Antiviral Res"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:48:38Z","timestamp":1572263318000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169159\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,5,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557519666190119111125","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}